2,818
Views
0
CrossRef citations to date
0
Altmetric
Special Focus: Nanotoxicology: Materials & Methods - Foreword

Nanotoxicology: Toxicity and Biological Effects of Nanoparticles for New Evaluation Standards

Pages 759-761 | Published online: 27 Jul 2011

Bibliography

  • Amin RM , MohamedMB, RamadanMA, VerwangerT, KrammerB. Rapid and sensitive microplate assay for screening the effect of silver and gold nanoparticles on bacteria. Nanomedicine (Lond.)4(6), 637–643 (2009).
  • Muthu MS , WilsonB. Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy. Nanomedicine (Lond.)5(2), 169–171 (2010).
  • Bai X , SonSJ, ZhangSXet al. Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling. Nanomedicine (Lond.) 3(2), 163–174 (2008).
  • Nie S . Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond.)5(4), 523–528 (2010).
  • Son SJ , BaiX, LeeSB. Inorganic hollow nanoparticles and nanotubes in nanomedicine part 1. Drug/gene delivery applications. Drug Discov. Today12, 650–656 (2007).
  • Boczkowski J , LanoneS. Potential uses of carbon nanotubes in the medical field: how worried should patients be? Nanomedicine (Lond.)2(4), 407–410 (2007).
  • Son SJ , BaiX, NanA, GhandehariH, LeeSB. Template synthesis of multifunctional nanotubes for controlled release. J. Control. Release114, 143–152 (2006).
  • He B , KimSK, SonSJ, LeeSB. Shape-coded silica nanotubes for multiplexed bioassay: rapid and reliable magnetic decoding protocols. Nanomedicine (Lond.)5(1), 77–88 (2010).
  • Oberdöster G , OberdösterE, OberdösterJ. Nanotoxicoloty. An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect.113, 823–839 (2005).
  • Faunce TA , WhiteJ, MatthaeiKI. Integrated research into the nanoparticle–protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomedicine3(6), 859–866 (2008).
  • Singh N . Nanotoxicology: health and environmental impacts. Nanomedicine (Lond.)4(4), 385–390 (2009).
  • Park MV , LankveldDP, van Loveren H, de Jong WH. The status of in vitro toxicity studies in the risk assessment of nanomaterials. Nanomedicine (Lond.)4(6), 669–685 (2009).
  • Faunce T , WatalA. Nanosilver and global public health: international regulatory issues. Nanomedicine (Lond.)5(4), 617–632 (2010).
  • Donaldson K , MurphyF, SchinwaldA, DuffinR, PolandCA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (Lond.)6(1), 143–156 (2011).
  • Almeida JPM , ChenAL, FosterA, DrezekR. In vivo biodistribution of nanoparticles. Nanomedicine (Lond.)6(5), 815–835 (2011).
  • Hirsch C , RoessleinM, KrugHF, WickP. Nanomaterial cell interactions: are current in vitro tests reliable? Nanomedicine (Lond.)6(5), 837–847 (2011).
  • Kong B , SeogJH, GrahamLM, LeeSB. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine (Lond.)6(5), 929–941 (2011).
  • Nerl HC , ChengC, GoodeAEet al. Imaging methods for determining uptake and toxicity of carbon nanotubes in vitro and in vivo. Nanomedicine (Lond.) 6(5), 849–865 (2011).
  • Fubini B , FenoglioI, TomatisM, TurciF. Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials. Nanomedicine (Lond.)6(5), 899–920 (2011).
  • Choi S-J , Choy J-H. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. 6(5), 803–814 (2011).
  • Zhang LW , BäumerW, Monteiro-RiviereNA. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (Lond.)6(5), 777–791 (2011).
  • Garcia-Bennett AE . Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine (Lond.)6(5), 867–877 (2011).
  • Stensberg MC , WeiQ, McLamoreE, PorterfieldDM, WeiA, SepúlvedaMS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond.)6(5), 879–898 (2011).
  • Chou LYT , ChanWCW. A strategy to assemble nanoparticles with polymers for mitigating cytotoxicity and enabling size tuning. Nanomedicine (Lond.)6(5), 767–775 (2011).
  • Hong S , KimKY, WookHJet al. Attenuation of the in vivo toxicity of biomaterials by polydopamine surface modification. Nanomedicine (Lond.) 6(5), 793–801 (2011).
  • Graham LM , NguyenTM, LeeSB. Nanodetoxification: emerging role of nanomaterials in drug intoxication treatment. Nanomedicine (Lond.)6(5), 921–928 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.